Hi Fjear,
that depends on the economics. If the future profits justifiy the purchase price then t/o will happen.
Key input parameters to the DFS include:
Capital Cost Estimate
A$69 million
Operating Cost estimate (per tonne of ore processed)
A$84
Operating Cost / mtu WO3
After molybdenum bi-product credits
Assuming 75% recovery of WO3
US$115
Revenue / mtu WO3
Source Roskill October 2011. (After APT discounts)
US$360
Annual throughput of ore
400,000 tpa
Tungsten recovery
75%
Molybdenum recovery
77.8%
Scheelite concentrate produced annually
2,200 tpa
Molybdenum concentrate produced annually
1,250 tpa
Let's simplify and just go with $ 200 profit per mtu.
annual profit 80 million, current MC 30 million ( including AIM ), so it would make sense to take us over for up to 6c / 4p. Even if the set up costs for a mine would be 100m, after 2 years they would break even.
That's why I am buying, it is extremely undervalued. But explain that to the impatient and uneducated.
- Forums
- ASX - By Stock
- cappers are back
THR
thor energy plc
Add to My Watchlist
0.00%
!
1.0¢

Hi Fjear,that depends on the economics. If the future profits...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.107M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 1.0¢ | $1K | 100K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 2076720 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 549771 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 2076720 | 0.009 |
8 | 1709333 | 0.008 |
6 | 1643979 | 0.007 |
5 | 1006833 | 0.006 |
2 | 577727 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 549771 | 6 |
0.011 | 6231 | 1 |
0.012 | 1643871 | 6 |
0.013 | 200000 | 1 |
0.014 | 255000 | 1 |
Last trade - 11.38am 25/06/2025 (20 minute delay) ? |
Featured News
THR (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online